Indivior Pharmaceuticals (INDV) Interest Expenses (2022 - 2026)
Indivior Pharmaceuticals' (INDV) quarterly Interest Expenses came in at $14.0 million in Q1 2026, up 16.67% year-on-year from $12.0 million in Q1 2025, and up 133.33% quarter-over-quarter from $6.0 million in Q4 2025.
Indivior Pharmaceuticals (INDV) Interest Expenses (2022 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Interest Expenses history runs 5 years deep, the most recent figure standing at $14.0 million for Q1 2026.
- On a quarterly basis, Interest Expenses rose 16.67% year-over-year to $14.0 million in Q1 2026; TTM through Mar 2026 was $14.0 million, a 68.89% decrease from a year earlier, with the FY2025 full-year figure at $55.0 million, up 17.02% from the prior year.
- Interest Expenses advanced to $14.0 million in Q1 2026 per INDV's latest filing, from $6.0 million in the prior quarter.
- Across five years, Interest Expenses topped out at $28.0 million in Q4 2023 and bottomed at $6.0 million in Q4 2025.
- The 5-year median for Interest Expenses is $12.0 million (2025), against an average of $13.8 million.
- Biggest YoY gain for Interest Expenses was 66.67% in 2025; the steepest drop was 53.85% in 2025.
- Year by year, Interest Expenses stood at $23.0 million in 2022, then advanced by 21.74% to $28.0 million in 2023, then tumbled by 53.57% to $13.0 million in 2024, then slumped by 53.85% to $6.0 million in 2025, then jumped by 133.33% to $14.0 million in 2026.
- Per Business Quant, the three latest INDV Interest Expenses figures stand at $14.0 million (Q1 2026), $6.0 million (Q4 2025), and $12.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 944.51 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.77 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.21 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 590.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Indivior Pharmaceuticals | 1.00 Bn | 829.65 Mn | 277.00 Mn | 14.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.00 Mn |
| Mar 31, 2026 | 14.00 Mn |
| Dec 31, 2025 | 6.00 Mn |
| Dec 31, 2025 | 6.00 Mn |
| Sep 30, 2025 | 12.00 Mn |
| Sep 30, 2025 | 12.00 Mn |
| Jun 30, 2025 | 15.00 Mn |
| Jun 30, 2025 | 15.00 Mn |
| Mar 31, 2025 | 12.00 Mn |
| Mar 31, 2025 | 12.00 Mn |
| Dec 31, 2024 | 13.00 Mn |
| Dec 31, 2024 | 13.00 Mn |
| Sep 30, 2024 | 11.00 Mn |
| Sep 30, 2024 | 11.00 Mn |
| Jun 30, 2024 | 9.00 Mn |
| Jun 30, 2024 | 9.00 Mn |
| Mar 31, 2024 | 9.00 Mn |
| Mar 31, 2024 | 9.00 Mn |
| Dec 31, 2023 | 28.00 Mn |
| Dec 31, 2023 | 28.00 Mn |